Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRSNASDAQ:EUDANASDAQ:PTWONASDAQ:TOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$3.55+4.7%$2.36$1.53▼$9.20$199.26M1.95200,467 shs542,086 shsEUDAEUDA Health$3.95+0.3%$3.83$2.21▼$6.30$146.75M-0.0581,417 shs80,255 shsPTWOPono Capital Two$11.00+1.0%$11.45$8.04▼$36.52$57.42M-0.0127,253 shs12,700 shsTOIOncology Institute$3.04+28.3%$1.86$0.13▼$3.50$229.70M0.04878,910 shs7.09 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies-3.69%+32.42%+90.99%-43.50%-25.66%EUDAEUDA Health-6.19%+5.63%-3.90%-3.90%+69.83%PTWOPono Capital Two0.00%0.00%0.00%0.00%-15.38%TOIOncology Institute-10.57%-13.50%+21.54%+160.44%+163.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIRSAirSculpt Technologies0.5721 of 5 stars1.00.00.00.02.45.00.0EUDAEUDA Health0.6287 of 5 stars0.03.00.00.03.30.00.6PTWOPono Capital TwoN/AN/AN/AN/AN/AN/AN/AN/ATOIOncology Institute2.1781 of 5 stars3.53.00.00.02.41.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 2.00Hold$3.755.63% UpsideEUDAEUDA Health 4.00Strong BuyN/AN/APTWOPono Capital Two 0.00N/AN/AN/ATOIOncology Institute 3.00Buy$7.00130.26% UpsideCurrent Analyst Ratings BreakdownLatest PTWO, AIRS, TOI, and EUDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025TOIOncology InstituteBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$7.003/31/2025AIRSAirSculpt TechnologiesLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$6.50 ➝ $2.50(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$172.10M1.21$0.14 per share25.15$1.46 per share2.43EUDAEUDA Health$4.01M36.59N/AN/A($0.30) per share-13.17PTWOPono Capital TwoN/AN/A$0.10 per share114.25($1.68) per shareN/ATOIOncology Institute$393.41M0.58N/AN/A$0.77 per share3.95Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$4.48M-$0.30N/A∞N/A-4.13%2.22%0.90%N/AEUDAEUDA Health-$10.04MN/A0.00N/AN/AN/AN/AN/A7/29/2025 (Estimated)PTWOPono Capital Two$340KN/A0.00∞N/AN/A-68.16%-5.23%N/ATOIOncology Institute-$83.07M-$0.71N/A∞N/A-17.63%-186.83%-34.58%N/ALatest PTWO, AIRS, TOI, and EUDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025TOIOncology InstituteN/A-$0.18N/A-$0.21N/A$104.41 million3/24/2025Q4 2024TOIOncology Institute-$0.08-$0.14-$0.06-$0.14$109.15 million$100.27 million3/14/2025Q4 2024AIRSAirSculpt Technologies-$0.03-$0.08-$0.05-$0.09$38.99 million$39.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/APTWOPono Capital TwoN/AN/AN/AN/AN/ATOIOncology InstituteN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.800.510.51EUDAEUDA HealthN/A0.13N/APTWOPono Capital TwoN/A0.320.32TOIOncology Institute5.912.492.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%EUDAEUDA Health4.35%PTWOPono Capital Two60.82%TOIOncology Institute36.86%Insider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies76.58%EUDAEUDA HealthN/APTWOPono Capital Two63.90%TOIOncology Institute8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24058.78 million12.56 millionOptionableEUDAEUDA Health237.15 millionN/ANot OptionablePTWOPono Capital TwoN/A5.22 million1.88 millionNot OptionableTOIOncology Institute66075.56 million68.38 millionNot OptionablePTWO, AIRS, TOI, and EUDA HeadlinesRecent News About These CompaniesOncology Institute Shares Rise After Higher 1Q RevenueMay 15 at 3:14 PM | marketwatch.comThe Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 GuidanceMay 15 at 3:14 PM | finanznachrichten.deTOI reaffirms 2025 guidance with $460M–$480M revenue target as capitation contracts fuel growthMay 15 at 10:12 AM | msn.comQ1 2025 Oncology Institute Inc Earnings CallMay 15 at 10:12 AM | finance.yahoo.comThe Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call TranscriptMay 15 at 12:02 AM | seekingalpha.comThe Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical OfficerMay 14 at 4:05 PM | globenewswire.comTopicus.com Inc. Announces Election of Members of the Board of DirectorsMay 13 at 7:36 PM | globenewswire.comThe Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor ConferenceMay 13 at 4:05 PM | globenewswire.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Down 5.48%May 10, 2025 | aaii.comConstellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025May 7, 2025 | globenewswire.comThe Oncology Institute: Insiders Buy Up Big While Valuations Are MurkyMay 6, 2025 | seekingalpha.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Down 6.07%May 5, 2025 | aaii.comThe Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24%May 5, 2025 | uk.finance.yahoo.comTopicus.com Inc. Defers Release Date for First Quarter ResultsMay 1, 2025 | globenewswire.comOncology Institute (NASDAQ:TOI) Stock Price Up 6.3% - Still a Buy?April 26, 2025 | marketbeat.comThe Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference CallApril 23, 2025 | globenewswire.comTopicus.com Inc. Announces Release Date for First Quarter ResultsApril 14, 2025 | globenewswire.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 9.33%April 10, 2025 | aaii.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 17.46%April 3, 2025 | aaii.comWhy The Oncology Institute, Inc.’s (TOI) Stock Is Up 10.53%April 2, 2025 | aaii.comThe Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025April 1, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePTWO, AIRS, TOI, and EUDA Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$3.55 +0.16 (+4.72%) As of 04:00 PM EasternAirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.EUDA Health NASDAQ:EUDA$3.95 +0.01 (+0.25%) As of 03:59 PM EasternEUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.Pono Capital Two NASDAQ:PTWOPono Capital Two, Inc. does not have any significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Pono Capital Two, Inc. was incorporated in 2022 and is based in Honolulu, Hawaii.Oncology Institute NASDAQ:TOI$3.04 +0.67 (+28.27%) As of 04:00 PM EasternThe Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas An Acquisition Just Made Dick's the Most Exciting Stock in Retail Walmart Stock Alert: Big Price Move Expected Soon Broadcom Set to Surge as AI Diffusion Rule Ends Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins Is Bally’s Turnaround a Safe Bet Amid Mixed Investor Sentiment? SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start Intel Makes a Cool Move With Shell, But Will Investors Warm Up? AMD’s AI-Powered Stock Price Rally Just Shifted Gears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
